Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients Undergoing a Methadone Maintenance Treatment

NCT02062723 is registered in ClinicalTrials.gov with L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. as lead sponsor.

NCT NCT02062723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02062723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients Undergoing a Methadone Maintenance Treatment
Lead sponsor
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
February 28, 2013
Enrollment
515 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

heroin addiction